Both in Pharmaceuticals
Sarepta Therapeutics, vs Trevi Therapeutics
Over the past year SRPT returned −22.0% and TRVI returned +30.3%; their daily moves had a correlation of 0.24.
SRPT −22.0% TRVI +30.3%Growth of $1, one year, split-adjusted
| Metric | SRPT | TRVI |
|---|---|---|
| Price | $19.06 | $13.94 |
| Market cap | $2.01B | $1.99B |
| Today | +2.80% | +0.58% |
| 1 month | +10.1% | +5.8% |
| 6 months | −17.2% | −2.2% |
| Year to date | −11.4% | +11.3% |
| 1 year | −22.0% | +30.3% |
| Revenue growth (YoY) | −34.3% | — |
| Gross margin | 62.8% | — |
| Net margin | −1.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | — |
| Net cash | -$59.1M | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 39.3% |
| Short % of float | 22.7% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).